news

29 January 2025: QScint Installs iQID NSight Medium

29 January 2025: QScint announces installation of iQID NSight Mini particle imager at UK Essen

Essen, Germany and Tucson, AZ - January 29, 2025 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID NSight Medium particle imager at Universitätsklinikum Essen. The installation expands QScint’s world-wide install base to an important nuclear medicine research site in Europe.

“Our latest install in Germany highlights QScint’s commitment to expanding into the European market” said Dr. Brian Miller, President of QScint. “We’re excited to see the cutting-edge research produced by Dr. Lückerath’s lab.”